Guardant Health, Inc. financial data

Symbol
GH on Nasdaq
Industry
Services-Medical Laboratories
Location
3100 Hanover Street, Palo Alto, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 633 % +4.91%
Quick Ratio 30.8 % +3.01%
Debt-to-equity 853 % -30.7%
Return On Equity -246 % +53.5%
Return On Assets -25.9 % +35.1%
Operating Margin -87.9 % +23.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122 M shares +19.1%
Common Stock, Shares, Outstanding 122 M shares +18.6%
Entity Public Float 4.1 B USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 122 M shares +18.6%
Weighted Average Number of Shares Outstanding, Diluted 122 M shares +18.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 604 M USD +25.2%
Research and Development Expense 358 M USD -7.09%
Selling and Marketing Expense 300 M USD -3.85%
General and Administrative Expense 154 M USD -5.6%
Costs and Expenses 1.13 B USD +9.34%
Operating Income (Loss) -530 M USD +4.46%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -460 M USD +30.7%
Income Tax Expense (Benefit) 850 K USD -39.4%
Net Income (Loss) Attributable to Parent -461 M USD +30.7%
Earnings Per Share, Basic -3.92 USD/shares +39.7%
Earnings Per Share, Diluted -3.92 USD/shares +39.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.03 B USD +360%
Marketable Securities, Current 870 M USD +97.4%
Accounts Receivable, after Allowance for Credit Loss, Current 84.6 M USD -3.03%
Inventory, Net 63 M USD +35.5%
Assets, Current 1.31 B USD +18.5%
Property, Plant and Equipment, Net 138 M USD -15.2%
Operating Lease, Right-of-Use Asset 152 M USD -11%
Intangible Assets, Net (Excluding Goodwill) 8.29 M USD -24.9%
Goodwill 3.29 M USD 0%
Other Assets, Noncurrent 94.2 M USD +59.8%
Assets 1.7 B USD +12.8%
Accounts Payable, Current 37.6 M USD -44.1%
Accrued Liabilities, Current 67.2 M USD -64.7%
Contract with Customer, Liability, Current 22.6 M USD +65.6%
Liabilities, Current 220 M USD +7.77%
Contract with Customer, Liability, Noncurrent 5.3 M USD +55.9%
Operating Lease, Liability, Noncurrent 179 M USD -12.7%
Other Liabilities, Noncurrent 96.8 M USD +959%
Liabilities 1.64 B USD +5.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.8 M USD +60.5%
Retained Earnings (Accumulated Deficit) -2.26 B USD -25.7%
Stockholders' Equity Attributable to Parent 68.3 M USD
Liabilities and Equity 1.7 B USD +12.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.3 M USD +59.3%
Net Cash Provided by (Used in) Financing Activities -1.07 M USD -25.8%
Net Cash Provided by (Used in) Investing Activities 28.1 M USD -82.1%
Common Stock, Shares Authorized 350 M shares 0%
Common Stock, Shares, Issued 122 M shares +18.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.43 M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.13 B USD +405%
Deferred Tax Assets, Valuation Allowance 604 M USD +23.5%
Deferred Tax Assets, Gross 654 M USD +22.4%
Operating Lease, Liability 207 M USD -9.46%
Depreciation 40.4 M USD +11.3%
Payments to Acquire Property, Plant, and Equipment 6.93 M USD -7.84%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -464 M USD +30.7%
Lessee, Operating Lease, Liability, to be Paid 238 M USD -11.2%
Property, Plant and Equipment, Gross 276 M USD +5.57%
Operating Lease, Liability, Current 28 M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 28.1 M USD -13.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 33.2 M USD -1.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -541 K USD -129%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30.7 M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 24.5 M USD -11.9%
Deferred Tax Assets, Operating Loss Carryforwards 344 M USD +16.8%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD -100%
Current Income Tax Expense (Benefit) 1.23 M USD -10.8%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 36.9 M USD +24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.3 M USD -4.73%
Additional Paid in Capital 2.33 B USD +32.1%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 35 K USD -72.4%
Amortization of Intangible Assets 2.7 M USD 0%
Depreciation, Depletion and Amortization 10.7 M USD +3.55%
Deferred Tax Assets, Net of Valuation Allowance 1.05 M USD +107%
Share-based Payment Arrangement, Expense 95.5 M USD +3.67%
Deferred State and Local Income Tax Expense (Benefit) 0 USD -100%
Interest Expense 2.58 M USD +0.08%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%